Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07032766 · ClinicalTrials.gov registry record

Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures

A clinical trial of Pain Management and Rib Fracture Multiple, sponsored by Albert Einstein College of Medicine.

Recruiting
Registry status
220
Enrollment target
1
Study location

NCT07032766: Recruiting study of Pain Management and Rib Fracture Multiple, sponsored by Albert Einstein College of Medicine.

NCT07032766 is a study of Pain Management and Rib Fracture Multiple that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 220 participants, above the 148-participant average among 31 other Pain Management trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07032766, a study of Pain Management and Rib Fracture Multiple, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.

RECRUITING
Registry status
220 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to learn about the long-term effects of the serratus anterior plane block (SAPB) in adult patients who suffered multiple unilateral anterolateral rib fractures within 24 hours of patient presentation to the emergency department. The main question it aims to answer is: Does the SAPB for multiple anterolateral rib fractures demonstrate reduction in patient morbidity and mortality, including incidence of pneumonia, length of hospital stay, discharge disposition, and death, as compared to standard analgesic regimens. The SAPB will be performed if a physician trained in the SAPB is available within 24 hours of injury. If a trained physician is not available and the patient meets inclusion criteria, they will receive parental analgesia with opioid therapy. They will be followed until date of hospital discharge, up until 60 days.

Primary Outcome

The number of patients of hospital acquired pneumonia events will be summarized by study arm/group using basic descriptive statistics.

Study Locations (1)

New York

  • Jacobi Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-08-10
Est. Completion 2026-08
Albert Einstein College of Medicine

175 total trials

What NCT07032766 shows while recruiting

NCT07032766 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, above the 148-participant average among 31 other Pain Management trials with a reported enrollment target (49% higher).

The record links to 3 conditions, with Pain Management appearing as the primary indexed condition, and to 0 interventions.

NCT07032766 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07032766 about?

NCT07032766 is a clinical study titled "Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures". The goal of this observational study is to learn about the long-term effects of the serratus anterior plane block (SAPB) in adult patients who suffered multiple unilateral anterolateral rib fractures within 24 hours of patient presentation to the emergency department. The main question it aims to an...

What is the current status of trial NCT07032766?

This trial is currently recruiting. The enrollment target is 220 participants. The study started on 2025-08-10. Estimated completion is 2026-08.

What conditions does trial NCT07032766 study?

This clinical trial studies the following conditions: Pain Management, Rib Fracture Multiple, Serratus Anterior Plane Block.

Who is sponsoring clinical trial NCT07032766?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07032766 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain Management

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07032766's enrollment target sits among peer trials

220 8th of 31 higher than 24 of 31 other Pain Management trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07032766, the US trial registry maintained by the National Library of Medicine. NCT07032766 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.